Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size

BACKGROUND: The treatment schedules for stereotactic body radiotherapy (SBRT) for lung cancer vary from institution to institution. Several reports have indicated that stage IB patients had worse outcomes than stage IA patients when the same dose was used. We evaluated the clinical outcomes of SBRT...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Baba, Fumiya, Shibamoto, Yuta, Ogino, Hiroyuki, Murata, Rumi, Sugie, Chikao, Iwata, Hiromitsu, Otsuka, Shinya, Kosaki, Katsura, Nagai, Aiko, Murai, Taro, Miyakawa, Akifumi
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: BioMed Central 2010
Θέματα:
Research
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2955592/
https://ncbi.nlm.nih.gov/pubmed/20849623
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1748-717X-5-81
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια